Olema肿瘤学首席执行官在J. P. Morgan会议上介绍乳腺癌药物发展情况。 Olema Oncology's CEO to present on breast cancer drug developments at J.P. Morgan conference.

研发针对乳腺癌的向治疗方法的Olema Oncology公司将在2025年1月14日下午3点45分的J.P.摩根医疗保健会议上邀请其首席执行官肖恩·P.博恩出席. Olema Oncology, a company developing targeted therapies for breast cancer, will have its CEO Sean P. Bohen present at the J.P. Morgan Healthcare Conference on January 14, 2025, at 3:45 p.m. PT. 该演示将进行网播,涵盖该公司的输油管,包括第3阶段试验候选人Palazestrant和KAT6抑制剂。 The presentation, which will be webcasted, covers the company's pipeline, including palazestrant, a Phase 3 trial candidate, and a KAT6 inhibitor. 参与者可以通过该公司的投资者关系网站访问材料。 Attendees can access materials through the company’s Investor Relations website.